Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: van Woerkom, Reijer
DOB: 26-DEC-1941 (Age: 83)
Gender: male
Address:
Dorpsstraat 112
2761 AN Zevenhuizen (Netherlands)
ID: 2279-613165-8
Report
Date: 15-OCT-2020
Laboratory
Requested by
Gezondheidscentrum Pijnacker
2641 DT Pijnacker (Netherlands)
Specimen
Collected: 14-OCT-2020

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 14 Oct 2020 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 183.0 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 128.1 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 126.9 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.4 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile shows borderline elevated LDL and low HDL cholesterol, which increases cardiovascular risk, especially in elderly patients. Total cholesterol and triglycerides are within normal limits. Consider lifestyle modification and, if indicated, pharmacological intervention to improve HDL and optimize lipid profile. Regular monitoring is recommended.